Beta-Lactams for Treatment of Cns Disorders
    1.
    发明申请
    Beta-Lactams for Treatment of Cns Disorders 审中-公开
    用于治疗Cns病的β-内酰胺类

    公开(公告)号:US20080262041A1

    公开(公告)日:2008-10-23

    申请号:US10595662

    申请日:2004-11-10

    CPC分类号: C07D401/04

    摘要: The present invention relates to novel compounds of formula (I): wherein — represents a single or a double bond; R is a radical selected from: in which R1 is halogen, cyano, C1-4 alkyl, C1-4 alkoxy, trifluoromethyl or trifluoromethoxy and p is zero or an integer from 1 to 3; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen, hydroxy or C1-4 alkyl; R4 is hydrogen or R4 together with R3 represents ═O or ═CH2; R5 is phenyl, naphthyl, a 9 to 10 membered fused bicyclic heterocyclic group or a 5 or 6 membered heteroaryl group, wherein said groups are optionally substituted by 1 to 3 groups independently selected from trifluoromethyl, C1-4 alkyl, hydroxy, cyano, C1-4 alkoxy, trifluoromethoxy, halogen or S(O)qC1-4 alkyl; R6 and R7 independently are hydrogen, cyano, C1-4 alkyl; R8 is (CH2)rR10; R9 is hydrogen, halogen, C3-7 cycloalkyl, hydroxy, nitro, cyano or C1-4 alkyl optionally substituted by one or two groups selected from halogen, cyano, hydroxy or C1-4 alkoxy; R10 is hydrogen or C3-7 cycloalkyl; n is 1 or 2; q is 0, 1 or 2; r is 0 or an integer from 1 to 4; or a pharmaceutically acceptable salt or a solvate thereof, process for their preparation and their use in the treatment of conditions mediated by tackykinins and/or by selective inhibition of the serotonin reuptake transporter protein

    摘要翻译: 本发明涉及新的式(I)化合物:其中 - 表示单键或双键; R是选自以下的基团:其中R 1是卤素,氰基,C 1-4烷基,C 1-4烷氧基,三氟甲基 或三氟甲氧基,p为0或1至3的整数; R 2是氢或C 1-4烷基; R 3是氢,羟基或C 1-4烷基; R 4是氢或R 4与R 3一起代表-O或-CH 2; R 5是苯基,萘基,9至10元稠合双环杂环基或5或6元杂芳基,其中所述基团任选被1至3个独立地选自三氟甲基, 烷基,羟基,氰基,C 1-4烷氧基,三氟甲氧基,卤素或S(O)q C 1-4烷基; R 6和R 7独立地是氢,氰基,C 1-4烷基; R 8是(CH 2 2)r R 10; R 9是氢,卤素,C 3-7环烷基,羟基,硝基,氰基或C 1-4烷基,任选被一个或多个 两个选自卤素,氰基,羟基或C 1-4烷氧基的基团; R 10是氢或C 3-7环烷基; n为1或2; q是0,1或2; r为0或1至4的整数; 或其药学上可接受的盐或溶剂合物,其制备方法及其用于治疗由粘蛋白介导的病症和/或通过选择性抑制5-羟色胺再摄取转运蛋白